In the glioblastoma cell line GL-15 the inhibition of ERK1/2 by the MEK inhibitors PD98059 reduces the mRNA levels for the KCa3.1 channels, suggesting that the same modulation described in T lymphocytes is also working in glioblastoma models [32]. This evidence concerns the gene KCNN4 and glioblastoma.